Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1120 participants
OBSERVATIONAL
2009-10-31
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Design of the study: Multicentric, prospective, epidemiological study in the field of usual clinical practice.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients
NCT03413696
Re-linkage to Care of Patients With Hepatitis C
NCT04470271
Quality of Life in Patients With HCV Related Liver Cirrhosis Before and After Direct Acting Antiviral Drugs
NCT03897608
Relinking Diagnosed But Untreated HCV Patients Back Into Care.
NCT05975216
Pattern of Skin Manifestations in Chronic Hepatitis c Virus Patients Before and After Direct Acting Anti Viral Drugs
NCT03170076
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hepatitis C infection
Adherence questionnaire
Adherence questionnaire
Hepatitis C + HIV infections
Adherence questionnaire
Adherence questionnaire
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Adherence questionnaire
Adherence questionnaire
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient no treated previously and beginning a treatment for HCV.
* Patient that signed the informed consent to participate in the study.
* Group A: patient with HCV monoinfection.
* Group B: patient with HCV and HCV co-infection (according to diagnosis criteria used en usual clinical practice).
Exclusion Criteria
* Patient that is going to participate in a clinical trial Turing the HCV treatment period.
* Patient with cognitive impairment or patient unable to understand and answer the auto-administered questionnaire.
* Patient unable to read or write Spanish.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundacion IMIM
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital del Mar
Barcelona, Barcelona, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ADH-HEPC-2009-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.